According to the latest news report, Akums Drugs and Pharmaceuticals Limited has collaborated with Lyrus Life Sciences to ensure the launch of patented drugs and formulations that are beneficial to patients. This news was published in Economic Times, Healthworld.
As a result of this partnership, the treatments and therapies that will arise are supposed to have more patient-friendly formulations. A number of patented products and technologies are in the pipeline that would address unmet needs in various therapeutic areas. A special focus would be on obesity, diabetes, pain, seasonal flu, psoriasis, respiratory insufficiency, immunity, and women’s health. The target patients would include mostly geriatric and pediatric populations.
Akums has stated that this collaboration has come at a crucial stage when the company is seeking to launch differentiated formulations, after receiving global patent rights. The company looks forward to a healthy partnership with Lyrus Life Sciences that would enable the medical fraternity to receive more innovative products. With the newly forged ties, Akum is committed to serve domestic and international markets.
Source: Akums, Lyrus Life Sciences collaborate for patented technologies and formulations. ETHealthWorld. 22 February, 2023.
https://health.economictimes.indiatimes.com/news/pharma/akums-lyrus-life-sciences-collaborate-for-patented-technologies-and-formulations/98148284#:~:text=Exclusive-,Akums%2C%20Lyrus%20Life%20Sciences%20collaborate%20for%20patented%20technologies%20and%20formulations,that%20are%20beneficial%20for%20patients
